Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasiveā¦ (NCT06214533) | Clinical Trial Compass
UnknownNot Applicable
Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery
60 participantsStarted 2024-03-01
Plain-language summary
The goal of this study is to assess the efficacy of intraoperative celiac plexus block (CPB) to reduce opioid consumption following laparoscopic hepato-pancreato-biliary surgery
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Over age 18
* Undergoing laparoscopic hepato-pancreato-biliary surgery
Exclusion Criteria:
* Patient refuse
* Relatively contraindications: severe heart, liver, or kidney dysfunction, coagulation dysfunction, and local anesthetic allergy history
* Intervention unlikely to be effective: drug abuse history, receiving other types of nerve block treatment
* Unlikely to complete the follow-up: alcoholism, planned to replace WeChat and phone within three months; the expected life span less than three months
* Unable to cooperate with the questionnaire and use the patient-controlled analgesia pump
What they're measuring
1
Postoperative opioid use
Timeframe: Up to 24 h after surgery
Trial details
NCT IDNCT06214533
SponsorSixth Affiliated Hospital, Sun Yat-sen University